Progyny Inc logo

PGNYProgyny Inc

NASDAQ · Healthcare · Healthcare Plans

$25.45

-$0.20 (-0.78%)

Progyny Inc (PGNY) is a healthcare plans company listed on NASDAQ. It is led by Peter Anevski CPA, based in 1359 Broadway, New York, NY, United States, 10018, with about 675 employees. Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Latest reported PGNY revenue for 2025-09-30 was $313.3M. Net income was $46.0M. Revenue was down 5.9% from 2025-06-30 to 2025-09-30. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.

Use this PGNY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PGNY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PGNY SEC filings page. Lician reads the product cache first so this HTML stays unique to Progyny Inc even when a live quote feed is slow.

About Progyny Inc

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

PGNY Key Statistics

Market Cap

$1.84B

Volume

814,697

Previous Close

$25.65

Day Range

$25.34$25.89

P/E Ratio

37.65

0

EPS

$0.12

Revenue

$298.43M

Net Income

$54.34M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+10.6%

Profit Margin

18.2%

Employees

675

PGNY Financials

Annual income statement in USD. Latest reported periods first.

PGNY annual income statement across FY2024, FY2023
LineFY2024FY2023
Revenue$298.43M$269.94M
Cost of Revenue$0.00$0.00
Gross Profit$0.00$0.00
Operating Income$0.00$0.00
Net Income$54.34M$62.04M
EPS (Diluted)$0.12$0.13

Total Assets

$607.10M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$162.31M

Operating Cash Flow

$179.10M

Free Cash Flow

$0.00

Progyny Inc Company Information

CEO & Director
Peter Anevski CPA
Headquarters
1359 Broadway, New York, NY, United States, 10018
Phone
212 888 3124
IPO / Founded
2019-10-25
Industry
Healthcare Plans
Data Updated:

Upcoming Events for PGNY